
Multiple Sclerosis
Latest Articles
ArticleSep 16, 2025
Disease Progression Monitoring
ArticleSep 16, 2025
Mechanism of Smoldering Disease
ArticleSep 16, 2025
Smoldering Disease Detection
ArticleSep 16, 2025
Smoldering Disease Burden
ArticleSep 16, 2025
Smoldering Disease Overview
ArticleSep 16, 2025
ArticleSep 5, 2025
Inside MS: Explore how BTK drives immune cell activation and CNS damage
ArticleSep 5, 2025
Tolebrutinib Direct Effects on Myeloid Cells in PwMS
ArticleJul 16, 2025
Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity
ArticleJun 4, 2025
Smoldering Neuroinflammation
ArticleMay 20, 2025
Slowing of brain atrophy with Teriflunomide
ArticleMay 20, 2025
Why has our brain suddenly become of interest?
ArticleMay 20, 2025
The reason for MS – beyond focal inflammation
ArticleMay 20, 2025
The importance of deep grey matter in MS
ArticleMay 20, 2025
Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice
ArticleMay 20, 2025
ArticleMay 20, 2025
Measuring brain atrophy. What can be done and where are we heading?
ArticleMay 20, 2025
ArticleMay 20, 2025
Falling chronically ill – How do I cope and move forward?
ArticleMay 20, 2025
Exercise as ”medicine” in the treatment of MS
ArticleMay 19, 2025
Cognitive training – A curse or a blessing?
ArticleMay 19, 2025
Cognitive decline – The invisible burden of MS?
ArticleMay 19, 2025
A promising biomarker in MS: Neurofilament light chain